Red Light Holland's new tech acquisition is intended to help optimize psychedelics dosing.
Articles
Cybin Launches EMBARK and Co-Sponsors First Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Burnout and Distress with Psychedelic-Assisted Psychotherapy
Cybin is launching a new clinical trial to address "COVID-related burnout and distress", supported by its new EMBARK psychotherapy model.
Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms
Mydecine announces identifying 40 previously unknown "novel compounds" among dozens of mushroom species it has screened.
Field Trip Virtually Opens The Market
Field Trip Health has uplisted to the TSX in Canada.
Psilocybin therapy appears to be at least as effective as a leading conventional antidepressant
Psilocybin, the active compound in magic mushrooms, may be at least as effective as selective serotonin reuptake inhibitors, the leading type of antidepressant medication, according to research published in the New England Journal of Medicine.
CBD shows promise in the treatment of anxiety — but more research is needed, particularly among women
A new report published in the journal Cannabis and Cannabinoid Research presents an overview of the clinical findings concerning the effectiveness of cannabidiol in the treatment of anxiety.
New Connecticut Marijuana Legalization Bill Released, With Votes Expected This Week
Connecticut legislative leaders introduced a sweeping new marijuana legalization bill late on Saturday, a day after announcing they’d reached a deal with the governor.
Louisiana Medical Marijuana Patients Gain Safe Access to Smokable Weed
Lawmakers in Louisiana approved HB 391, finally permitting smokable forms of cannabis for medical marijuana patients in the state.
Increasing Interest in Psychedelics for Medical Purposes
Investors are always looking for hot new markets to invest in.
American Support For And Understanding Of Psychedelic Drugs Continues To Broaden
A Psychedelic Drug Revolution is underway to address the Mental Health Crisis. As with all revolutions, we are seeing a rapid shift in attitudes.
Activist: Massachusetts Cannabis Industry Responsible for 10% of State’s Industrial Energy Use
A Northeast Sustainable Cannabis Project representative told lawmakers on Tuesday that the Massachusetts cannabis industry is responsible for 10% of all industrial electricity use in the state and urged them to allow industry cultivators to use organic farming and outdoor technics, according to a MassLive report.
Arizona Supreme Court Launches Site To Help People Expunge Marijuana Convictions
The Arizona Supreme Court on Wednesday announced that it has launched a website to help people expunge their past marijuana conviction records, pursuant to the legalization initiative that voters approved last year.
Feds Should Work With—Not Against—States That Legalize Psychedelics, Government Health Official Says
Oregon’s move to legalize psilocybin mushrooms for therapeutic use should signal to the federal government that it needs to engage with jurisdictions that pursue such reforms and aid in the development of regulatory frameworks, a federal health official says.
New York Bill Would Create State-Sponsored Psychedelics Research Institute
A New York lawmaker introduced a bill on Tuesday that would require the state to establish an institute to research the therapeutic potential of psychedelics.
Novamind Reports Fiscal Q3 Financial Results and Operating Highlights
Novamind's clinic revenues jumped 43% quarter-over-quarter, to CAD$1.85 million. Projecting a 225% increase in clinic visits year-over-year.